Glycogen synthase kinase 3beta regulates GATA4 in cardiac myocytes.
about
Hairy-related transcription factors inhibit GATA-dependent cardiac gene expression through a signal-responsive mechanismThe EDD E3 ubiquitin ligase ubiquitinates and up-regulates beta-catenin.Microsomal prostaglandin E synthase-1 promotes hepatocarcinogenesis through activation of a novel EGR1/β-catenin signaling axisJumonji represses atrial natriuretic factor gene expression by inhibiting transcriptional activities of cardiac transcription factorsMechanical stretch up-regulates microRNA-26a and induces human airway smooth muscle hypertrophy by suppressing glycogen synthase kinase-3βAdult murine skeletal muscle contains cells that can differentiate into beating cardiomyocytes in vitroGATA transcription factors as tissue-specific master regulators for induced responsesThe Developmental Intestinal Regulator ELT-2 Controls p38-Dependent Immune Responses in Adult C. elegansThe beta-catenin/T-cell factor/lymphocyte enhancer factor signaling pathway is required for normal and stress-induced cardiac hypertrophyCardiomyocyte GATA4 functions as a stress-responsive regulator of angiogenesis in the murine heartmiR-145 inhibits isoproterenol-induced cardiomyocyte hypertrophy by targeting the expression and localization of GATA6Molecular role of GATA binding protein 4 (GATA-4) in hyperglycemia-induced reduction of cardiac contractilityGATA-4 is a nuclear mediator of mechanical stretch-activated hypertrophic programGrowth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heartAnalysis of the signals and mechanisms mediating nuclear trafficking of GATA-4. Loss of DNA binding is associated with localization in intranuclear specklesChronic high fat diet induces cardiac hypertrophy and fibrosis in mice.GSK-3: Functional Insights from Cell Biology and Animal Models.ERβ selective agonist inhibits angiotensin-induced cardiovascular pathology in female miceTEAD-1 overexpression in the mouse heart promotes an age-dependent heart dysfunction.GSK3beta: role in therapeutic landscape and development of modulators.Glycogen synthase kinase 3beta contributes to proliferation of arterial smooth muscle cells in pulmonary hypertension.Motility, survival, and proliferation.Constitutive glycogen synthase kinase-3alpha/beta activity protects against chronic beta-adrenergic remodelling of the heart.Inhibition of cardiomyocyte hypertrophy by protein arginine methyltransferase 5Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice.Promyelocytic leukemia zinc finger protein activates GATA4 transcription and mediates cardiac hypertrophic signaling from angiotensin II receptor 2.Cardioprotection of controlled and cardiac-specific over-expression of A(2A)-adenosine receptor in the pressure overloadBeta-adrenergic signaling in the heart: dual coupling of the beta2-adrenergic receptor to G(s) and G(i) proteins.In vivo gene delivery of XIAP protects against myocardial apoptosis and infarction following ischemia/reperfusion in conscious rabbits.Targeting GSK-3 family members in the heart: a very sharp double-edged sword.Dysfunctional ryanodine receptor and cardiac hypertrophy: role of signaling moleculesDesmin regulates airway smooth muscle hypertrophy through early growth-responsive protein-1 and microRNA-26aRe-employment of developmental transcription factors in adult heart diseaseGlycogen synthase kinase-3beta plays a pro-apoptotic role in beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes: Role of beta1 integrins.Transcription factor GATA4 is activated but not required for insulin-like growth factor 1 (IGF1)-induced cardiac hypertrophyInhibition of GSK-3beta as a target for cardioprotection: the importance of timing, location, duration and degree of inhibition.Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysisChronic treatment with insulin-like growth factor I enhances myocyte contraction by upregulation of Akt-SERCA2a signaling pathway.Myocardial AKT: the omnipresent nexus.Deletion of GSK-3beta in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation.
P2860
Q24306881-29127CAD-B634-442F-8255-CB34ECC9A574Q24310085-7E3EB88E-778F-4F84-ABE7-B7C3805523F2Q24312971-F81541B7-5409-4B5D-AF1A-829C56A0A006Q24559996-03B4A053-36A3-4EC6-8927-A388F28C3A27Q24610983-46BABDCF-9396-469D-A256-8E2CDC6E1930Q24797989-7457C5D7-05D4-4D33-AE6E-D9F60A25977EQ26749187-83B3DF1F-F601-4E54-A4BD-501CF33F40F3Q27311093-451D06BC-DF8B-47D0-85A0-1635F3BC49D1Q28243220-8FA824E8-1F07-4882-9D90-3425237FD621Q28509556-09998718-B630-4351-9B92-623E3BF12EF1Q28565449-F9044BD0-C78C-43A0-AA31-DE174A5AE0B5Q28566976-3361BC11-771E-4828-ACF7-C299E37F15D7Q28569972-EB4A5C31-13A3-422E-AD4B-88BA56232174Q28576178-8A0A451D-7CF2-49AC-A3E4-24E8885F8FCFQ28585947-0E5F8DE6-B281-4E6B-96AD-E95E20EF6D9DQ30299931-E8EF2B7F-01C4-427D-A654-0441A9FDB4E1Q30472813-9C8A19C6-0DC8-45ED-B889-402A94A3FA33Q33584903-5056D9CA-E057-4284-8D53-EA392962D85FQ33810072-1AF8FEB4-70A5-44F0-BE45-04DC6492B5F8Q33812730-B2CF4140-85AD-4A15-BFA1-545680C61268Q33886299-CB16D95F-9174-4225-B2A7-B1E40303D6C9Q33997601-0FDFDA99-9E78-4C26-89CA-553709225205Q33997638-7F5E1824-07C6-42ED-AD49-CD66C4E9EAEEQ34107266-33232478-985F-4E7F-A21A-C980772C5580Q34156036-83A91447-C651-4965-A2D8-AE6ADB1B68CBQ34256543-D7C87BB9-8745-486D-956F-8DE6083E5235Q34335762-B89BE9E9-911E-4F9A-9C39-5D82CA2350CCQ34403963-C60FFB41-9EF1-441C-84F2-0AE2FBB2CD8DQ34717828-ABD08129-E8B2-4DB0-B7C3-A7C16556CF08Q34785999-D48EA977-103C-469E-94F0-75C0A1404E87Q35056963-526CA02E-E977-4421-BEF6-AB3859332668Q35604477-1467F99C-C96A-4DE1-A29C-6252E4985C7FQ35757916-70C916B1-612C-40C7-8FB5-FB0F226574F0Q35847201-88ADDF77-DDD8-47A3-9B7D-21DA30E88289Q35880015-52F9FBD5-4925-4BB9-99DF-5E2434772C5FQ36158687-EFB0BDCD-788C-46C6-98D3-20CD5BC13A5DQ36497030-85BF9B9F-00DA-4233-9E6C-F0542036F977Q36807914-3471161D-A58B-4918-92E5-BEC26E4C1FD3Q36908289-044576FA-BF7E-440D-B766-DF5709BD56D8Q36915017-A6E46D0C-A919-4301-8FA4-F6929B3E78AA
P2860
Glycogen synthase kinase 3beta regulates GATA4 in cardiac myocytes.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Glycogen synthase kinase 3beta regulates GATA4 in cardiac myocytes.
@en
Glycogen synthase kinase 3beta regulates GATA4 in cardiac myocytes.
@nl
type
label
Glycogen synthase kinase 3beta regulates GATA4 in cardiac myocytes.
@en
Glycogen synthase kinase 3beta regulates GATA4 in cardiac myocytes.
@nl
prefLabel
Glycogen synthase kinase 3beta regulates GATA4 in cardiac myocytes.
@en
Glycogen synthase kinase 3beta regulates GATA4 in cardiac myocytes.
@nl
P2093
P2860
P356
P1476
Glycogen synthase kinase 3beta regulates GATA4 in cardiac myocytes.
@en
P2093
P2860
P304
28586-28597
P356
10.1074/JBC.M103166200
P407
P577
2001-05-29T00:00:00Z